On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Thomas M. MacDonald

ResearcherPublications, citations & collaboration network

Thomas M. MacDonald is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Thomas M. MacDonald have?

ScholarIQindexed works

Thomas M. MacDonald has 558 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Thomas M. MacDonald have?

ScholarIQcitation count

Thomas M. MacDonald has 20,775 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Thomas M. MacDonald?

ScholarIQh-index

Thomas M. MacDonald has an h-index of 73 in OpenAlex.

What is the i10-index of Thomas M. MacDonald?

ScholarIQi10-index

Thomas M. MacDonald has an i10-index of 261 in OpenAlex.

What is the ORCID of Thomas M. MacDonald?

ScholarIQorcid

The ORCID for Thomas M. MacDonald is on the source record.

What is the OpenAlex record for Thomas M. MacDonald?

ScholarIQopenalex

The OpenAlex for Thomas M. MacDonald is on the source record.

What are the most-cited papers on Thomas M. MacDonald?

ScholarIQmost cited works
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Bryan Williams, Thomas M. MacDonald, S. V. Morant, David J Webb, Peter Sever, Gordon T. McInnes, Ian Ford, J. CRUICKSHANK, Mark J. Caulfield, Jackie Salsbury, Isla S. Mackenzie, Sandosh Padmanabhan, Morris J. Brown
The Lancet. 20151,273 CitationsOPEN ACCESS
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
Bryan Williams, Thomas M. MacDonald, S. V. Morant, David J Webb, Peter Sever, Gordon T. McInnes, Ian Ford, J.K. Cruickshank, Mark J. Caulfield, Sandosh Padmanabhan, Isla S. Mackenzie, Jackie Salsbury, Morris J. Brown, Karthik Balakrishnan, Timothy J. Burton, Jeremy W. Cannon, David Collier, C Coughlan, Richard D’Souza, Enamuna Enobakhare, Elizabeth Findlay, Caroline Gardiner-Hill, Pankaj Gupta, Joanna Helmy, C Helmy, Laura Hobbs, Richard Hobbs, Sally G. Hood, Ray K. Iles, Sharon Kean, See Kwok, P Lacy, I. MacIntyre, Judith Mackay, Nirmala D. Markandu, Una Martin, Linsay McCallum, Gerry P McCann, Andrew W. McGinnis, Vanessa Melville, S. Muir, KS Myint, Salik Nazir, J. Palmer, Richard Papworth, Krzysztof Rutkowski, Manjari Saxena, A. Schumann, Handrean Soran, A Stanley, Simon Thom, David J. Webb, C.W. White, Robert Wilson, Zák A
The Lancet Diabetes & Endocrinology. 2018340 CitationsOPEN ACCESS
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis
Daniel L. Levin, Samira Bell, Reijo Sund, Sirpa Hartikainen, Jaakko Tuomilehto, ­Eero Pukkala, Ilmo Keskimäki, Ellena Badrick, Andrew G. Renehan, Iain Buchan, Samantha L. Bowker, Jasjeet K. Minhas‐Sandhu, Zafar Zafarí, Carlo A. Marra, Jeffrey Johnson, Bruno H. Stricker, André G. Uitterlinden, Albert Hofman, Rikje Ruiter, Catherine E. de Keyser, Thomas M. MacDonald, Sarah H. Wild, Paul McKeigue, Helen M. Colhoun
Diabetologia. 2014155 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account